Products for Research Use Only
RegisterLogin

DTP3

CAT: 0804-HY-100538-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-100538-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DTP3 TFA is a potent and selective GADD45β/MKK7 inhibitor. DTP3 TFA targets an essential, cancer-selective cell-survival module downstream of the NF-κB pathway[1].
CAS Number
1809784-29-9
UNSPSC
12352209
Hazard Statement
H302, H315, H319, H335
Target
DNA/RNA Synthesis; JAK
Type
Peptides
Related Pathways
Cell Cycle/DNA Damage; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dtp3.html
Purity
98.45
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : ≥ 100 mg/mL
Smiles
O=C(N[C@H](CC1=CC=CC=C1)C(N)=O)[C@H](NC([C@H](NC(C)=O)CC2=CC=C(O)C=C2)=O)CCCNC(N)=N
Molecular Formula
C26H35N7O5
Molecular Weight
525.60
Precautions
H302, H315, H319, H335
References & Citations
[1]Tornatore L, et al. Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7inhibitor and clinical candidate, DTP3. Toxicol Rep. 2019 Apr 19;6:369-379.|[2]Tornatore L, et al. Cancer-selective targeting of the NF-κB survival pathway with GADD45β/MKK7 inhibitors. Cancer Cell. 2014 Oct 13;26 (4) :495-508.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-112114DTPA-DAB2
HY-W011118-01DTPA anhydride
HY-W738256Maleimide-DTPA
HY-107078DTPA-adenosylcobalamin
HY-156035-01Bz-DTPA
HY-163650-01DTPD-Q
HY-155446Di-DTPA-LTL
HY-151725N3-Pen-Dtpp
HY-W717782Bz-DTPA (hydrochloride)
HY-155445Di-DTPA TL

Alternative Products

CatalogName
BA4004-25DTP3
A16059-25DTP3 25mg
M30129DTP3 TFA
A16059-100DTP3 100mg
555974DTP3 inhibitor

Popular Products